Skip to main content

Table 2 Comparison of intra- and post-procedural characteristics

From: Prophylactic intraoperative tranexamic acid administration and postoperative blood loss after transapical aortic valve implantation

  Total TXA-group Non-TXA-group p
(n = 146) (n = 54) (n = 92)
Time of operation (min) 98.3 ± 27.9 99.2 ± 27.0 100.0 ± 29.0 0.354
Rethoracotomy (n) % (11) 7 (2) 4 (9) 10 0.221
Serum Crea 72 h after TA-AVI (mg/dL) 1.5 ± 0.8 1.4 ± 0.8 1.4 ± 0.8 0.436
Need for haemodialysis (n) % (15) 10 (5) 9 (10) 11 0.751
Major neurologic deficit (n) % (3) (1) 2 (2) 2 0.946
Major thrombembolic complication (n) %* (2) 1 (1) 2 (1) 1 0.662
ICU stay (day) 4.2 ± 3.0 4.3 ± 3.2 4.2 ± 3.0 0.909
Hospital stay (day) 11.8 ± 5.8 10.8 ± 4.4 11.9 ± 5.6 0.586
30-day mortality (n) % (17) 11 (6) 11 (11) 12 0.988
  1. Hb: Hemoglobin; ICU: intensive care unit; TA-AVI: transapical aortic valve implantation.
  2. *One episode of pulmonary embolism occurred in either group on 4th and 5th POD.